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ABSTRACT Reaction of the Schiff-base complex
[Co(acetylacetonate-ethylenediimine)(NH3)2]1 with metmyo-
globin at pH 6.5 yields a partially folded protein containing six
Co(III) complexes. Although half of its a-helical secondary
structure is retained, absorption and CD spectra indicate that
the tertiary structure in both B-F and AGH domains is
disrupted in the partially folded protein. In analogy to proton-
induced unfolding, it is likely that the loss of tertiary structure
is triggered by metal-ion binding to histidines. Cobalt(III)-
induced unfolding of myoglobin is unique in its selectivity
(other proteins are unaffected) and in allowing the isolation
of the partially folded macromolecule (the protein does not
refold or aggregate upon removal of free denaturant).
Partially folded proteins are polypeptides with substantial
secondary structure in a largely disordered tertiary structure
(1–4). They are often referred to as ‘‘molten globules’’ (1, 4,
5). Because of increased flexibility, hydrophobic amino acid
residues may become exposed in a molten globule, leading to
a higher membrane affinity (as compared with a fully folded
protein), an attribute that could be of importance in biological
processes (1, 6). Aggregates formed in vivo from partially
folded proteins contribute to a number of important human
disease states, such as Alzheimer’s disease, other amyloidoses,
and the prion diseases (7–9). So far, partially folded proteins
have been obtained from their more stable folded precursors
either under equilibrium conditions in nonphysiological dena-
turing media or as short-lived kinetic intermediates in rapid
folding experiments (1), but, with the exception of protein
aggregates (7–9), they have not been isolated.¶
The reaction between a cobalt(III) Schiff base complex,
[Co(acetylacetonate-ethylenediimine)(NH3)2]† (1) (10, 11,
42), and metmyoglobin (metMb) yields a partially folded
protein isolated in a biologically relevant medium.¶ Uniquely,
most other proteins are not affected by 1 under the same
conditions, demonstrating that this novel unfolding method
can be highly selective. Mechanistic studies indicate that the
irreversibility and selectivity of unfolding by 1 originate in the
strong bond formed preferentially between cobalt and an
imidazole nitrogen of a histidine. Our findings open the way for
applications based on the unique properties of molten globules
as toxin-like prodrugs (6).
MATERIALS AND METHODS
Materials. [Co(acacen)L2]Cl (acacen 5 acetylacetonate-
ethylene-diimine; L 5 NH3, 1; L 5 imidazole, 2; L 5 4-Me-
imidazole, 3; L 5 N-Me-imidazole, 4; L 5 2-Me-imidazole, 5;
L 5 MeNH2, 6) complexes were prepared by literature meth-
ods (10). Horse skeletal muscle metMb and apoMb (Sigma)
were of the highest purity available and were used as received.
Spectroscopy. UVyvis absorption spectra were acquired on
a Hewlett Packard HP 8452 diode array spectrophotometer.
CD spectra were measured on an Aviv 62DS spectropolarim-
eter at 25°C (1-mm cell for far-UV CD; 10-mm cell for
near-UV CD). Measurements were made on the incubation
mixtures, without additional treatment, before dissociation of
weakly bound Co(III) complexes. Note, however, that removal
of free 1 by dialysis did not change the spectrum of the
incubation product of metMb with 11 equivalents of 1. The
200-MHz 1H NMR spectrum (hemin region) of metMb (1
mM) with excess 2 ([2]0 5 12 mM) in 0.05M sodium phosphate
buffer (pH 7.0) at 25°C was measured on a Bruker (Billerica,
MA) AM200.
Unfolding Experiments. Different amounts from a stock
solution of the relevant cobalt complex in 0.01 M sodium
phosphate buffer solution at pH 6.5 were added to a metMb
or apoMb solution in the same medium. Volume corrections
with pure buffer solution (so that a final reaction volume of 20
ml would be reached) were done before addition of the cobalt
solution. The final protein concentration was 1z102 5 M (except
for determining the concentration dependence of the 222-nm
CD signal on the protein concentration). Incubation was for
96 h at 22°C. The protein products were analyzed after dialysis
of the free cobalt, unless otherwise mentioned. Dialysis at 4°C
was either from bags (3,000-D cutoff) for 12 h against pure
buffer solutions or from Centricon concentrators (3,000 D,
Amicon).
Determination of the Cobalt-to-Protein Binding Ratio. Fi-
nal protein concentrations were determined by the Folin–
Ciocalteu method (12). [1] after dialysis was determined by
graphite furnace atomic absorption of cobalt [duplicate 20-ml
samples were examined, by using argon as the inert gas; the
absorbance was measured at 240.7 nm (0.2-nm slit, 1 s) on a
Varian SpectrAA-20, equipped with PSC-56 and GTA-96].
Binding ratios are rounded to the nearest whole number.
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Attempts to Reverse the Unfolding. These experiments were
carried out on 1025-M solutions of the unfolded protein from
which the free unfolding reagent was removed by dialysis. The
reaction with excess dithionite was run for 3 h under argon
before the UVyvis spectrum of the solution was recorded. The
product was exposed to air, and the spectrum was remeasured.
The reactions with excess imidazole (25, 200, and 105) were
followed periodically by UVyvis absorption. The reaction with
25-fold excess hemin (solubilized in a minimum volume of a
0.01-M NaOH solution) was allowed to proceed at room
temperature for 24 h. The solution was passed through a
Sephadex G-25 column (1.5z20 cm) to separate the free hemin,
and the absorption spectrum was acquired.
Ligand Exchange. Reactions of complexes 4 and 5 with free
imidazole occur in water. UVyvis absorptions of these reaction
mixtures were monitored at three or four different wavelengths
(per experiment) in which the absorbance difference between
the starting compound and the expected product (prepared
separately) was maximized. The Co(III) complex concentra-
tion was 10 mM, and the free ligand was in 25- and 200-fold
excess. NMR spectral analysis of the initial and final solution
established the identity of the products.
RESULTS AND DISCUSSION
Incubation of metMb with 1 leads to broadening, a strong
decrease in the molar extinction coefficient and a blue shift of
the Soret band in the absorption spectrum from 409 (« 5
1.7z105) to 392 nm (« ' 5.9z104 M21zcm21) (Fig. 1). The
intraligand p–p* band of 1 shifts from 334 to 340 nm, with no
apparent change in extinction coefficient («334 5 7100
M21zcm21). A minimum Co(III)-to-protein ratio of 11 to 1 is
required for the full spectroscopic transformation (Fig. 2A).
The far UV CD shows a 50% decrease in the a-helical
secondary structure of metMb (Fig. 2B)i that parallels the
decrease in the Soret band (Fig. 2A). The loss of the near-UV
CD (Fig. 2D) indicates diminished packing around the aro-
matic amino acids. At an initial 1:metMb ratio of 11:1, virtually
no near-UV CD signal is observed.
To verify that the loss of CD signal intensity loss is not
related to protein aggregation in experiments conducted with
10 mM metMb or less, the dependence of the CD signal at 222
nm on the metMb concentration was determined (keeping
[metMb]:[1] 5 10 and other conditions as reported in Fig. 2).
A linear correlation was obtained between 1 and 18 mM
metMb (data not shown).
The reaction is irreversible in the sense that extensive
dialysis leaves an average of six cobalt complexes associated
with the protein and that the product retains 1 for prolonged
periods in solution even in the absence of free 1. External
reagents reverse the reaction. Excess dithionite reduces the
hemin to ferroheme and causes cobalt dissociation from the
protein [probably by reducing Co(III) to labile Co(II)].
Exposure to air regenerates metMb. A large excess of
imidazole leads to slow, incomplete recovery of the Soret
band. Excess hemin does not affect the product UVyvis
spectrum.
ApoMb reacts with 1 much faster than metMb, and a smaller
1-to-apoMb ratio completes the transformation ['6:1
1:apoMb (Fig. 3A)]. The product is identical with the one
obtained from metMb and excess 1 [overlapping far-UV CD
(Fig. 3B), with 6 Co(III) complexes bound to the protein]. The
observation that these products are the same indicates that 1
causes hemin dissociation from the active site of metMb.**
The similarity of the electronic spectrum of metMb after
reaction with 1 with that of free hemin in a polar medium (15)
also supports this conclusion.
The far-UV CD and UVyvis spectral changes (Fig. 2 A and
B) are similar to those obtained upon treatment of metMb with
acid or low concentration guanidinezHCl (16–18), where it is
well established that there is disruption of the tertiary struc-
ture in the B-F folding domain (19–21). Evidence for unfolding
by 1 in this region is based on the fact that the active site is
contained within this domain and includes our observation of
hemin dissociation and the correlation between that dissoci-
ation (monitored by the Soret absorption) and the changes in
the protein secondary structure (as indicated by [U]222) (Fig.
2 A and B).
Because the near-UV CD bands at l . 268 nm are due to
electronic transitions in tryptophans and tyrosines (22, 23),
they probe the tertiary structure of horse myoglobin only in the
AGH domain, where such residues are found (24). The
disappearance of the near-UV CD features suggests that this
domain loses its tertiary fold upon reaction with 1. In contrast,
near-UV CD (25–27) and other studies (19–21) indicate that
the AGH domain remains largely intact upon myoglobin
unfolding by acid or low concentration guanidinezHCl.
The partially unfolded Co(III)-myoglobin can be described
as a molten globule (1, 4, 5) because it retains much secondary
structure but very little tertiary structure (Fig. 2D). Because all
free denaturant can be removed, this is in every sense an
isolated, kinetically stable, partially folded protein.
[Co(acacen)(imidazole)2]1 (2) reacts differently than 1 with
metMb. Only one molecule of 2 binds each protein, causing no
change in the Soret absorption and only a small change in the
far-UV CD (Fig. 2C). The 4-methyl- and N-methyl-imidazole
derivatives of 1 (complexes 3 and 4) behave as 2 toward metMb
(only 1 cobalt binds), whereas the 2-methyl-imidazole and
methylamine derivatives (complexes 5 and 6) react like 1 (6
cobalts bind to the protein). Nevertheless, 2 unfolds apoMb.
The CD unfolding profile at 222 nm is similar to that of 1 (Fig.
3A), although only three cobalt complexes are bound to the
isolated product.
Some of the imidazole liberated by the reaction of metMb
with 2 binds at the active site, generating low spin imidazole-
bound hemin in equilibrium with high spin water-bound
hemin. This conclusion is based on the paramagnetic 1H-NMR
spectrum of metMb with excess 2, which is a superposition of
the spectra of native metMb and imidazole-bound metMb
(data not shown). Removal of the imidazole by dialysis regen-
iMyoglobin unfolded by urea and guanidinium chloride retains virtu-
ally no helicity (13).
**The dissociated hemin is not separated from the cobalt–myoglobin
product by dialysis, as confirmed by iron atomic absorption mea-
surements. It probably binds nonspecifically to the unfolded protein,
as observed by Hargrove and Olson (14).
FIG. 1. UVyvis absorption spectral changes during the incubation
of metMb and 1 in 0.01 M sodium phosphate, at pH 6.5 and 25°C, with
15-min intervals between measurements. [metMb]0 5 10 mM, [1]0 5
0.18 mM.
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erates a pure high spin species.†† When this product is reacted
with excess 2, no low spin product is observed by 1H NMR
because the cobalt binding site remains occupied after removal
of unreacted 2. This evidence strongly suggests that the
reaction of metMb with 2 involves cleavage of the cobalt-
imidazole bond and replacement of this ligand by a protein side
chain with ligating capabilities.
The small changes in wavelength (6-nm shift) and extinction
coefficient of the p-p* absorption band of 1 (Fig. 1) indicate
that it binds to a nitrogen donor of the protein. Although these
values are similar for ammonia, alkylamines, pyridine, and
substituted imidazoles as axial ligands (10, 11), they do change
upon replacement of a nitrogen donor by an oxygen donor
(28). Moreover, attempts to prepare [Co(acacen)(amino ac-
id)2]1 complexes in which amino acids bind h1 through a
carboxylate oxygen have failed, resulting in binding only to the
amino group (29). Ligand exchange experiments demonstrate
that 1 and 2 prefer histidines over lysines. Indeed, two imida-
zole equivalents replace both ammines of 1 in water at 25°C,
whereas no reaction is observed between 2 and two equivalents
of n-butylamine. Thus, we conclude that the protein ligand in
the 1-Mb derivative is a histidine imidazole.
The kinetic lability of the Co(III) axial ligand is important
in determining the reaction product with metMb. This is
apparent upon comparing complexes 2, 3, 4, and 5. Ligand
exchange of 5 with excess imidazole is much faster than the
analogous reaction with 4 and is attributed to steric repulsion
between the methyl group at the imidazole 2-position and the
cis disposed Schiff base. Because 2, 3, and 4 bind only to one
(or two, if bridging, see below) of the exposed histidines of
metMb,‡‡ it would appear that ligand exchange on the cobalt
center of 2, 3, or 4 is assisted by interactions with the protein.§§
The fact that, during unfolding, apoMb binds six molecules of
1, but only three of 2, supports this suggestion.
Why do 1 and 5 unfold metMb, whereas other histidine
modifiers {2, [Ru(NH3)5(H2O)]21 (31) and [Ru(en)2(H2O)2]21
(en 5 1,2-ethylenediamine) (32)} do not? An intriguing expla-
nation is that 1 and 5, which could dissociate sequentially both
axial ligands, bind to two trans-disposed histidines.¶¶ Possible
support for this suggestion is the observation that six (on average)
molecules of 1 bind to unfolded myoglobin. Horse myoglobin has
11 histidines, therefore this number may reflect five pairs of
cobalt-bridged histidines, plus a histidine that is bound predom-
inantly to a nonbridging cobalt (interprotein linking by cobalt is
also a possibility).
The interaction of Co(III) with one or more surface histi-
dines is a likely initial step in the unfolding of metMb. The
relative rates of unfolding by 1 are metMb ,, apoMb, indi-
cating that hemin dissociation is rate-determining. Hence, the
parallel changes of the hemin absorption at 408 nm (Fig. 2A)
and the backbone far-UV CD (Fig. 2B) imply that hemin
dissociation precedes unfolding, as suggested for metMb un-
folding under equilibrium conditions** (33). Barrick and
Baldwin have proposed that two protons per protein unfold
apoMb (34) by disrupting the structurally important His24 to
His119 hydrogen bond (35). Like Co(III), Zn21 and Cu21
††The position and intensity of the band at 340 nm confirm that the
acacen ligand remains bound to cobalt. The p-p* transition of the
uncomplexed ligand is at 323 nm (11).
‡‡As many as six surface histidines on metMb can be modified (30).
Three [Ru(NH3)5]21 complexes can be bound to metMb without
perturbing the protein structure (31).
§§This assistance probably depends on neighboring side chain inter-
actions with the cobalt complex. Protonation of the axial ligand by
an acidic residue is a likely possibility.
¶¶Cobalt(III) Schiff-base complexes differ from other d6 complexes in
their higher axial ligand labilities (29).
FIG. 2. (A) Soret absorbance as a function of the initial concentration ratios of metMb and 1. (B and C) CD at 222 nm after incubating metMb
with (B) 1 or (C) 2. (D) Near-UV CD after incubating metMb with 11 equivalents of 1. All spectra were taken after 96 h at 22°C in 0.01 M sodium
phosphate at pH 6.5. [metMb]0 5 10 mM.
FIG. 3. (A) CD at 222 nm after incubating apoMb (7.5 mM) with
1 and 2. (B) Far-UV CD after incubating metMb and apoMb with 11
equivalents of 1. Conditions as given in the Fig. 2 legend.
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associate with the histidines of metMb, probably triggering
partial unfolding (15, 36). It is reasonable, therefore, to
propose that metal cations play a role similar to that of protons
in their interactions with apoMb.
The unfolding of metMb by 1 is highly selective. Under the
same reaction conditions, neither the absorption nor the
far-UV CD spectra of cytochrome c, azurin, thrombin, and
thermolysin (37) are affected by treatment with 1; and the
catalytic activity of carbonic anhydrase is not diminished (37).
Unlike metMb, these proteins do not possess enough accessi-
ble metal-ion binding sites, and they probably do not have
histidines that are involved in structurally critical hydrogen
bonds (unlike apoMb), thus explaining their markedly differ-
ent behavior toward Co(III). By using suitably structured
metal complexes, it should be possible to unfold proteins rich
in other hydrogen bond-forming amino acids, in addition to
those that possess a single hydrogen bond that is critical for
tertiary structure stabilization.
Molten globules are superior to folded proteins in their
ability to translocate across or insert into membranes (6)
because they have increased affinity for hydrophobic surfaces
(1). Therefore, an isolatable partially folded protein can be a
powerful new type of pro-drug, functioning in a manner similar
to that suggested for some bacterial toxins (6). Metal-ion-
induced unfolding also may be used for selective protein
precipitation, thereby aiding the formation of solid inclusion
bodies, which could lead to improvements in large scale
protein biosynthesis (8).
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